SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-08-048061
Filing Date
2008-07-28
Accepted
2008-07-28 17:01:19
Documents
2
Period of Report
2008-07-24

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1515
2 EX-24.1 ex-24d1.htm EX-24.1 17065
  Complete submission text file 0001104659-08-048061.txt   20470
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTERLEUKIN GENETICS 135 BEAVER STREET WALTHAM MA 02452
Business Address (781) 398-0700
Armstrong Glenn S (Reporting) CIK: 0001440929 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32715 | Film No.: 08973534